Vanguard reports 5.26% stake in Organon (13.7M shares)
Organon & Co reported that Vanguard Capital Management beneficially owned 13,717,181 shares of Common Stock, representing 5.26% of the class as of 03/31/2026.
Rhea-AI Filing Summary
Organon & Co reported that Vanguard Capital Management beneficially owned 13,717,181 shares of Common Stock, representing 5.26% of the class as of 03/31/2026. The filing lists 1,980,163 shares as sole voting power and 13,717,181 shares as sole dispositive power. The disclosure attributes ownership to Vanguard Capital Management LLC and affiliated Vanguard entities.
Positive
- None.
Negative
- None.
Insights
Vanguard reports a >5% stake in Organon, showing institutional scale ownership.
The filing documents 13,717,181 shares (5.26%) beneficially owned as of 03/31/2026, with dispositive authority held by Vanguard Capital Management LLC and named affiliates. This is a standard Schedule 13G disclosure of beneficial ownership by an investment manager.
Actual voting and disposition are concentrated: 1,980,163 shares of sole voting power versus 13,717,181 shares dispositive. Subsequent filings may update holdings; timing and trading intent are not specified in this excerpt.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned financial
Sole dispositive power regulatory
Sole voting power regulatory
FAQ
What stake does Vanguard Capital Management report in Organon (OGN)?
Does the Schedule 13G name other entities tied to Vanguard's ownership?
Is Vanguard identified as owning more than 5% of Organon common stock?
Who signed the Schedule 13G for Vanguard Capital Management?
AI-generated analysis. How Rhea-AI works. Not financial advice.